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Abstract 
BACKGROUND: The present systematic review aimed to express the clinical anti-lipid effects of 
different types of herbs, as well as described studied interactions between herbal remedies and 
prescribed drugs for hyperlipidemic patients which were based on in vitro experiments, animal 
studies, and empirical clinical experiences. 
METHODS: For this systematic review, we explored 2183 published papers about herbal drugs 
interactions from November 1967 to August 2014, fulfilling eligibility criteria by searching in 
some databases such as Web of Science, Medline, Scopus, Embase, Cinahl, and the Cochrane 
database. The main keywords used for searching included: herbal medicine, herbs, statin, lipid, 
and herb-drug interaction. 
RESULTS: Among published articles about herb-drug interactions, 185 papers met the initial 
search criteria and among them, 92 papers were potentially retrievable including a description 
of 17 herbs and medicinal plants. In first step and by reviewing all published manuscripts on 
beneficial effects of herbs on serum lipids level, 17 herbs were described to be effective on lipid 
profile as lowering serum triglyceride, total cholesterol, low-density lipoprotein cholesterol as 
well as increasing serum high-density lipoprotein level. Some herbs such as celery could even 
affect the hepatic triglyceride concentrations. The herbal reaction toward different types of 
statins is varied so that grapefruit or pomegranate was interacted with only some types of 
statins, but not with all statin types. In this context, administration of herbal materials can lead 
to decreased absorption of statins or decreased the plasma concentration of these drugs. 
CONCLUSION: Various types of herbs can potentially reduce serum lipid profile with the 
different pathways; however, the herb-drug interactions may decrease pharmacological 
therapeutic effects of anti-hyperlipidemic drugs that should be considered when approved herbs 
are prescribed. 
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Introduction 
Ischemic heart disease is one of the major causes of 
mortality and disabilities whole of the world, 
particularly in developing countries. Because of its 
rapid progression in order to inappropriate lifestyle 
and nutritional modification, it has been produced 
as the greatest vulnerable event.1 The pattern of the 
spread of disease is highly associated with quality 
control of its major risk factors that among them, 
hyperlipidemia has the main staple role.2,3 
Nowadays, tend to use synthetic drugs to lower 
serum lipid in patients with hyperlipidemia is 
gradually decreased because of their related side 
effects, as well as a progression of drug resistance. 
In this regard, tend to use of medicinal plants has 
been doubled.4 However, in some cases, the multi-
drug prescription such as using synthetic drugs and 
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interaction that is a major concern of specialists in 
pharmacology. These interactions may also increase 
pharmacological therapeutic effect that is more 
important in drugs with low safety and narrow 
therapeutic indices.5 Unfortunately, the vast 
majority of these products are used unlicensed 
without the assessment of efficacy, safety, or 
quality. Furthermore, some herbal supplements are 
frequently associated with adverse events including 
all levels of severity, organ systems, and age groups 
that may worsen drug interactions when used in 
conjunction with chemical drugs.6 In addition, 
recent statistics have evidenced that as many as 16% 
of prescription drug users consume herbal 
supplements,7 fewer than 40% of patients disclose 
their herbal supplement usage to health care 
providers,8 and many physicians are unaware of the 
potential for herb-drug interactions.9 This 
knowledge deficiency evidently increases the 
likelihood of drug-herb interactions. The present 
systematic review aimed to express the clinical anti-
lipid effects of different types of herbs as well as 
described studied interactions between herbal 
remedies and prescribed drugs for hyperlipidemic 
patients which were based on in vitro experiments, 
animal studies, and empirical clinical experiences. 
Materials and Methods 
For this systematic review, we explored 2183 
published papers about herbal drugs interactions from 
November 1967 to August 2014, fulfilling eligibility 
criteria by searching in some databases such as Web of 
Science, Medline, Scopus, Embase, Cinahl and the 
Cochrane database. Our research was restricted to 
English language studies. The main keywords used for 
searching included: herbal medicine, herbs, statin, 
lipid, and herb-drug interaction. 
Studies were included, and eligible if evaluated 
herb-drug interactions in therapeutic regimens for 
treatment of hyperlipidemia. In this review, case 
reports were excluded. 
Papers matching inclusion criteria were reviewed 
in detail. Methodology of papers quality assessment 
was performed on the basis of some 
methodological elements that were previously 
described.10 These criteria were including: 
prospective data collection, method of sampling, 
age range specification, inclusion and exclusion 
items specification, study setting specification, 
measurement tools validation, definition of disease 
status, sex and age specific prevalence report, data 
collection description, study limitations and possible 
correlates of disease and complications. 
Among 2183 published articles about herb-drug 
interactions, 185 papers met the initial search 
criteria and among them, 92 papers were potentially 
retrievable including a description of 17 herbs and 
medicinal plants. 
Results 
Anti-lipid effects of herbs and related 
mechanisms 
Among all studies evaluating effects of herbs on 
lipid profile and also those who assessed 
interactions between these herbs and lipid-
lowering drugs, especially statins (Table 1), a 
minority of the studies focused on herb-drug 
interactions. Furthermore, with respect to the 
mechanisms of action as well as biological 
pathways involving drug interactions, these 
mechanisms have not been completely understood. 
In some experimental studies, the main 
mechanisms involved in reducing lipid levels or its 
effects increase of lipid-resistance to lipid 
oxidation induced by some co-factors such as 
Cu(2+) (Basil or Ocimum basilicum).11,12 Some 
herbal extracts acts as induced inhibition of lipid 
accumulation during adipogenesis particularly via 
improvement of triglyceride-rich lipoprotein 
catabolism (blueberry or Vaccinium myrtillus).13,14 
In some herbs, the main factors for the relevant 
bioactivity is enriched 9(Z)-octadecenamide 
(oleamide) and ethanolic extracts responsible for 
inhibition of lipid production leading lowering 
serum triglyceride, total cholesterol, low-density 
lipoprotein cholesterol (LDL-C) or even hepatic 
triglyceride (celery or Apium graveolens).15-17 Some 
herbs such as dandelion (Taraxacum officinale) 
acts via inhibition of adipocyte differentiation and 
lipogenesis in 3T3-L1 preadipocytes resulted in 
potentially decrease in different lipid profile 
including triglycerides, total cholesterol and LDL-
C, as well as increase of high-density lipoprotein 
cholesterol (HDL-C) level both within a mid-term 
administration time.18-20 The ethanolic extract of 
some herbs such as Eugenol or Eugenia jambolana 
can improve 3-hydroxy-3-methylglutaryl-coenzyme 
A reductase activity that has a potential role in 
regulating serum lipid profile. It was also shown 
that hypolipidemic effect of this agent can be due 
to the presence of flavonoids, saponins, glycosides, 
and triterpenoids in its extract.21-24 Modifying lipid 
peroxidation has been revealed as the main 
underlying mechanism of action in some herb 
extract (evening primrose oil) that is mediated by 
reduce of glutathione peroxidase activity and 
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increase of the activities of glutathione reductase 
and transferase.25-30 In fenugreek (Trigonella 
foenum-graecum), the main mechanisms 
responsible for lowering serum triglyceride and 
total cholesterol include activating lecithin-
cholesterol acyltransferase (47%), post heparin 
lipolytic activity (35%), triglyceride lipase (34%), 
lipoprotein lipase (20.8%), and increased excretion 
of fecal bile acids, as well as mediated through 
inhibition of fat accumulation and upregulation of 
LDL receptor (LDLR). In fact and at molecular 
level, thermostable extract of fenugreek seeds 
(TEFS) or TEFS can inhibit accumulation of fat in 
differentiating and differentiated 3T3-L1 cells 
through decreased expression of adipogenic 
factors such as peroxisome proliferators activated-
receptor-gamma (PPAR-gamma), sterol regulatory 
element-binding protein-1, and CAAT element-
binding proteins-alpha. Under sterol-enriched 
condition, TEFS up-regulated LDLR expression 
resulting in enhanced LDL uptake.31-33 These 
underlying pathways are particularly revealed in 
diabetic states.34-37 Ginger (Zingiber officinale) has 
been introduced as a lowering lipid peroxidation 
through its high acetylcholinesterase inhibitory 
activity. In fact, the inhibitory effect of ginger 
extracts on acetylcholinesterase activities and some 
prooxidants induced lipid peroxidation has been 
demonstrated that is usually mediated by effect on 
acetylcholinesterase activities, and sodium 
nitroprusside and quinolinic acid-induced lipid 
peroxidation.38-42 Ginseng is a powerful herb affect 
via inhibition the increases of total cholesterol, 
LDL-C and triglyceride and also the decrease of 
HDL-C by down-regulating lipid accumulation and 
up-regulating adiponectin expression in the 3T3-
L1 adipocyte cells. It seems that the main 
enzymatic pathways involved in this mechanisms 
include displaying 1,1-diphenyl-2-picrylhydrasyl 
and superoxide radical scavenging activities and 
inhibited hemolysis induced by 2,2’-azobis-2-
amidinopropane dihydrochloride in a dose-
dependent manner.42-45 The anti-lipid effects of the 
grape are mostly mediated by resveratrol 
component that can significantly lower oxidized 
LDL and elevate HDL-C level that can be 
beneficial in atherosclerosis prevention. Moreover, 
administration of grape seed procyanidin extract 
(GSPE) can reverse the increase in plasma 
phospholipids. The alterations in the lipid 
metabolic pathways induced by GSPE were 
accompanied by lower free fatty acid levels in the 
plasma and decreased lipid and triglyceride 
accumulation. In this pathway, the effect of the 
oligomeric and polymeric procyanidin fractions in 
grape can also be trigger for lipolytic enzyme 
activities.46-52 The strong effect of green tea 
polyphenols on reducing the body fat content and 
hepatic triacylglycerol and cholesterol 
accumulation has been also shown. It seems that 
green tea extract suppresses adiposity and affects 
the expression of lipid metabolism genes especially 
hepatic expression of the lipid catabolism genes acyl-
coenzyme A oxidase 1, palmitoyl (ACOX1), acyl-
coenzyme A dehydrogenase, c-4 to c-12 straight 
chain (ACADM), and peroxisome proliferator-
activated receptor alpha (PPAR-α).53-57 Analysis of 
methanolic extract and volatile oil extracted from 
Nigella sativa seed oil have shown reduction of the 
plasma triglycerides to near normal level and increase 
of HDL-C and its subfraction along with arylesterase 
activity levels caused by a significant decrease in 
hepatic hydroxymethylglutaryl (HMG)-CoA 
reductase activity.58-63  
 
Table 1. Herbs with hypolipidemic effects 
Name of herb Biological effects 
Basil Lowering LDL and total cholesterol, increase of HDL 
Blueberry Lowering triglyceride and LDL levels 
Celery Decreasing serum triglyceride, total cholesterol, LDL-C and hepatic triglyceride 
Dandelion Decreasing serum triglyceride, total cholesterol, LDL-C and increasing HDL-C 
Dill Decreasing serum triglyceride 
Eugenol Decreasing serum triglyceride, total cholesterol, LDL-C and increasing HDL-C 
Evening primrose oil Decreasing serum triglyceride, total cholesterol 
Fenugreek Decreasing serum triglyceride, total cholesterol, HDL-C 
Ginger Decreasing serum LDL-C and increasing HDL-C 
Ginseng Decreasing serum triglyceride, total cholesterol, LDL-C and increasing HDL-C 
Grape Lowering oxidized LDL and elevate HDL-C level 
Green tea Suppresses adiposity and affects the expression of lipid metabolism genes 
Nigella Decrease in triglyceride and increase in HDL-C 
Psyllium Decrease in LDL 
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The beneficial effects of psyllium has been more 
focused on its regulatory effects on different 
components of metabolic syndrome such as 
improve glucose levels and insulin response, blood 
pressure, as well as lipid profile in both animals and 
humans, thereby reducing metabolic risk factors. 
According to recent reports, the use of psyllium 
could decrease insulin sensitivity, reduce android fat 
to gynoid fat ratio, as well as a reduce LDL-C. 
However, its physiological pathways have been 
already questioned.64,65 Among different types of 
herbs, the position of dill as an anti-lipid agent is 
highlighted. Recent observations have been shown 
that the main hypolipidemic effect of this herb is 
order to activation of PPAR-α, an indispensable 
regulator for hepatic lipid metabolism by the 
extracts of dill caused by increased the mRNA 
expression levels of fatty acid oxidation-related 
genes in the liver and leading decrease of plasma 
triglyceride and glucose levels.66 Its effect has been 
also shown in some recent clinical trials especially 
on lowering serum triglyceride level.67 
Along with independent effects of the pointed 
herbs on lipid profile, some other herbal extracts 
such as red yeast rice or grapefruit indirectly 
influence serum lipid levels though their 
interactions with lipid-lowering drugs that are 
discussed in the next section. 
Interaction between herbs and lipid lowering 
drugs 
Regarding interaction between statin drugs and 
herbs which involved in lowering serum lipid 
profile, a few studies have been published. In a 
recent study by Rosenblat et al., although 
simvastatin with the dose 15 µg/ml could decrease 
macrophage cholesterol biosynthesis rate by 42% as 
compared to control cells, the combination of 
pomegranate and simvastatin resulted in an 
inhibitory effect up to 59% that was significant. 
Moreover, Simvastatin with the same dosage 
modestly decreased macrophage reactive oxygen 
species formation by 11% alone and by up to 63% 
concurrently with pomegranate.68 In another 
experiment on interactive effects of grapefruit juice 
on chemical drugs, it has been revealed that the 
main mechanism for this interaction include 
inhibiting CYP3A4, the cytochrome P450 
isoenzyme that most often involve in drug 
metabolism. With respect to interaction between 
grapefruit and statins, co-ingestion of this fruits can 
significantly elevated serum atorvastatin by 19-26% 
in one study and by 1.40 fold (95% confidence 
interval 1.02, 1.92) in another study compared with 
baseline and also elevated serum simvastatin by 3.6-
fold (range 1.8-6.0 fold); however, no significant 
changes were detected in any pravastatin 
pharmacokinetic parameter examined when 
pravastatin was taken with grapefruit juice.69-72 
Discussion 
The growing use of herbal remedies has far 
exceeded the increase in available information on 
their benefits, adverse effects and drug interactions. 
Although compounds isolated from herbs have 
been shown to have important pharmacologic 
activities, but in some observations, actions of the 
herbs have been overestimated or underestimated. 
Moreover, both administrators and costumers have 
little-evidenced information on safety, effectiveness, 
and adverse effects of these herbs. In this regard, 
the increasing number of foods containing herbs 
has raised concerns at the food and drug 
administration (FDA). 
Several herbs offer potential for cardiovascular 
conditions including hyperlipidemia, hypertension 
and congestive heart failure through a variety of 
mechanisms such as antioxidant, antiplatelet, 
fibrinolytic, anti-atherosclerotic, anti-
hyperlipidemic, antiarrhythmic and vasodilatory 
actions.73 The present study attempted to first 
review published evidence on the efficacy of herbs 
against hyperlipidemia as a potential coronary artery 
risk factor and after that it focused on some 
evidence on probable interactions between these 
herbs and anti-hyperlipidemic drugs, especially 
statins.74,75 In first step and by reviewing all 
published manuscripts on beneficial effects of herbs 
on serum lipids level, 17 herbs were described to be 
effective on lipid profile as lowering serum 
triglyceride, total cholesterol, LDL-C as well as 
increasing serum HDL level. Some herbs such as 
celery could even affect the hepatic triglyceride 
concentrations. Although all shown herbs had 
similar target points on serum lipids, but the 
physiological affectivity mechanisms of drugs was 
widely different, including changes in lipid oxidation 
(basil, dill), induce of inhibiting lipid accumulation 
by lipid catabolism (blueberry), inhibition of lipid 
production (celery), Inhibition of adipocyte 
differentiation and lipogenesis (dandelion, grape, 
and green tea), reducing lipid peroxidation (evening 
primrose oil and ginger), activation of lipase 
enzymes (fenugreek), up-regulation of adiponectin 
expression in adipocyte cell (ginseng), and decrease 
in hepatic HMG-CoA reductase activity (nigella). In 
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fact, different parts of lipid metabolism pathways 
can be affected by various types of herbs. 
According to similar effects of chemical drugs on 
lipid metabolism process, interaction between these 
drugs and herbs is expectable. However, few studies 
were implemented to clear these interactions. 
Regarding drug-herb interaction, the interaction 
between some types of herbs and statins that are 
commonly used for improving hyperlipidemia has 
been considered. As previously shown, the herbal 
reaction towards different types of statins is varied 
so that grapefruit or pomegranate were interacted 
with only some types of statins, but not with all 
statin types. In this context, administration of herbal 
materials can lead to decreased absorption of statins 
or decreased the plasma concentration of these 
drugs. Simvastatin, pravastatin, and lovastatin are 
inhibitors of HMG-CoA reductase, the rate-limiting 
step in cholesterol synthesis.9 Thus, any herbs 
involved in activation or inhibition of this 
enzymatic pathway can induce changes in drug 
absorption or catalysis. 
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